Examining Prenylated Xanthones as Potential Inhibitors Against Ketohexokinase C Isoform for the Treatment of Fructose-Driven Metabolic Disorders: An Integrated Computational Approach
Pharmaceuticals | Vol. 18 | 2025
DOI: https://doi.org/10.3390/ph18010126